The corporate governance department at Jones Day focuses on activism matters for major F&B, technology, and pharmaceutical corporations. The practice is jointly led by Randi Lesnick in New York and Joel May in Atlanta, who has expertise that extends to proxy contests, internal investigations and executive compensation front. In the activism space, a notable recent achievement was the negotiation of a cooperation agreement between the board of Catalent Inc. and an activist shareholder that resulted in the appointment of 4 new independent directors. Lesnick is adept at a variety of corporate matters, focusing on M&A, ESG, and general governance issues. May spends a lot of time in the boardroom, ensuring that clients in the telecommunications, real estate, and manufacturing sectors are SEC-compliant. Andrew Levine excels in activism defense in New York and recently negotiated a cooperation and information-sharing agreement on behalf of BioMarin Pharmaceutical with an activist shareholder. Other key names in the team include Braden Mccurrach in New York, Kimberly Pustulka out of Cleveland, and Pittsburgh’s David Grubman.
Legal 500 Editorial commentary
- Profile
- Social
Accolades
Client satisfaction
Key clients
- Board of Directors of Catalent Inc.
- Hanesbrands Inc.
- The Aaron's Company
- Board of Directors of BioMarin Pharmaceutical Inc.
- Board of Directors of UL Standards & Engagement
- GrafTech International Ltd.
- Matthews International Corporation
Lawyers
Practice head
Randi C. Lesnick; Joel T. May
Other key lawyers
Andrew Levine; Braden Mccurach; Kimberly Pustulka; David Grubman